Status:
COMPLETED
Optimized Single-breath Helium Lung Volume in Obstructive Lung Disease
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Obstructive Lung Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Whole-body plethysmography (WBP) is the gold standard for measuring lung volume, but its clinical application is limited because it requires expensive equipment and is complicated to use. Studies have...
Eligibility Criteria
Inclusion
- (1) age 18-80 years and (2) in line with the ATS/ERS definition of obstructive lung disease.
Exclusion
- (1) contraindications for spirometry, pulmonary diffusion function test, and WBP and (2) history of lung surgery and recent history of chest trauma.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
628 Patients enrolled
Trial Details
Trial ID
NCT04919200
Start Date
January 1 2018
End Date
December 31 2020
Last Update
June 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China